Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver Gene
Clinical trial NCT03905317 · UNKNOWN
Trial details
- NCT number
- NCT03905317
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2022-02-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.